| |
|
|
|
Corvus Pharma Com  
|
|
3.58 -0.21 (-0.06%) |
02-25 16:00 |
|
Open: |
3.77 |
Pre close: |
3.79 |
Target:
|
5.21
|
|
High: |
3.7877 |
Low: |
3.52 |
Resistance:
|
4.46
5.08
|
|
Volume: |
1,606,503 |
Market Cap: |
135M |
Support:
|
3.46
2.88
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.95
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
3.96 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
3.99 |
Stochastic Oscillator |
%K(14,3):
|
21.19 |
|
MA(250): |
3.60  |
%D(3): |
34.57 |
|
Average Volume(K) |
3-Month: |
74368
|
52-Week |
High:
|
6.88 |
|
10-Days: |
297930 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
44.30 |
Change(%): |
4.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.509 |
Return on Equity (ttm) |
-72.3 |
Shares Out. (M) |
28.04 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-38.2 |
Shares Float (M) |
14.90 |
|
EPS Est. Next Year |
-3.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.98 |
|
EPS Est. Next Quarter |
-0.840 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
63.75 |
|
Forward EPS |
-1.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1230 |
|
Book Value (p.s.) |
1.510 |
EBITDA (p.s.) |
-1.592 |
P/E |
-2.37 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.37 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.08 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.90 |
P/CF |
-2.86 |
|
|
|
|
|
|
